The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1976-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9378(76)90273-8PMID 183504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• On the presence within tumours of clones that differ in sensitivity to cytostatic drugs.

  2009cited by this paper
• Carcinoembryonic antigen assay in cancer of the colon and pancreas and other digestive tract disorders

  2005cited by this paper
• Placental proteins and their subunits as tumor markers.

  1975cited by this paper
• Competitive radioassays and "specific" tumor markers.

  1973cited by this paper
• Discordance of human chorionic gonadotropin and alpha‐fetoprotein in testicular teratocarcinomas

  1973cited by this paper
• Ectopic production of human chorionic gonadotrophin by neoplasms.

  1973cited by this paper
• A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone.

  1972cited by this paper
• POLYMORPHISM OF PROTEIN AND POLYPEPTIDE HORMONES 1

  1972cited by this paper
• Demonstration of an antigen common to several varieties of neoplasia.

  1971cited by this paper
• In search of a cancer.

  1971cited by this paper
• Ectopic production of human chorionic somatomammotropin by nontrophoblastic cancers.

  1971cited by this paper
• Trophoblastic disease: natural history, diagnosis, and treatment.

  1971cited by this paper
• Clinical and laboratory studies of ectopic humoral syndromes.

  1969cited by this paper
• The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system.

  1969cited by this paper
• Ectopic gonadotropin production before clinical recognition of bronchogenic carcinoma.

  1968cited by this paper
• Tumour growth and anti-mitotic action. The role of spontaneous cell losses.

  1968cited by this paper
• Serum placental lactogen levels during pregnancy and in trophoblastic disease.

  1966cited by this paper
• Humoral syndromes associated with cancer.

  1965cited by this paper

• Sex Cord-Stromal, Steroid Cell, and Other Ovarian Tumors with Endocrine, Paraendocrine, and Paraneoplastic Manifestations

  2019cites this paper
• Untersuchung zur prognostischen Wertigkeit von hCG und Glycodelin bei Frauen mit Ovarialkarzinom

  2013cites this paper
• Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer

  2012cites this paper
• Clinical significance of the preoperative carcinoem- bryonic antigen level in primary epithelial ovarian cancer

  2010cites this paper
• The detection and measurement of oncodevelopmental proteins in gynecological malignant disease

  2005influential citation
• Products of gynaecological neoplasms: Clinical and pathological applications

  2005cites this paper
• Human chorionic gonadotropin in cancer.

  2004cites this paper
• Evolution of screening for epithelial ovarian carcinoma: the quest for early diagnosis.

  1994cites this paper
• Evaluation of tumor-associated glycoprotein-72 and CA 125 serum markers in patients with gynecologic diseases.

  1994cites this paper
• Endocrine tumors of the ovary.

  1992cites this paper
• Human epithelial ovarian cancer cell steroid secretion and its control by gonadotropins.

  1991cites this paper
• Clinical syndromes associated with tumors of the female genital tract.

  1991cites this paper
• Hormone-producing tumors of the ovary

  1990cites this paper
• Ovarian tumors with functioning stroma an immunohistochemical study of 100 cases with human chorionic gonadotropin monoclonal and polyclonal antibodies

  1990cites this paper
• Hormone replacement therapy and cancer.

  1989cites this paper
• Transitional cell carcinoma in high‐grade high‐stage ovarian carcinoma. An indicator of favorable response to chemotherapy

  1989cites this paper
• Monoclonal antibodies: clinical applications.

  1989cites this paper
• Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.

  1987cites this paper
• Circulating tumor markers in the monitoring of gynecologic malignancies

  1987cites this paper
• Pros and cons of gynecologic tumor markers

  1987cites this paper
• An estimation of the molecular weight and location of maxillary cancer associated antigen.

  1986cites this paper
• Recent immunologic advances affecting the management of ovarian cancer.

  1985cites this paper
• [Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].

  1985cites this paper
• Immunohistochemical localization of tumor markers in epithelial ovarian cancer.

  1984cites this paper
• [Tumor markers in oncological gynecology].

  1984cites this paper
• Review of tumor markers for ovarian cancer.

  1984cites this paper
• [Immunohistochemical localization of human chorionic gonadotropin and human placental lactogen in placentas of various ages].

  1984cites this paper
• Tumour markers in ovarian cancer.

  1983cites this paper
• Biochemical aids in the monitoring of patients with ovarian cancer.

  1983cites this paper
• Screening for ovarian cancer.

  1983cites this paper
• An immunohistochemical study of the incidence and significance of human chorionic gonadotrophin synthesis by epithelial ovarian neoplasms.

  1983cites this paper
• Ectopic production of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) by ovarian carcinoma.

  1983cites this paper
• [Ovarian tumor biology].

  1982cites this paper
• A feasibility study in the development of biological markers for ovarian cancer

  1982cites this paper
• Tumor markers in inclusion cysts of the ovary

  1982cites this paper
• Facultative Malignant Ovarian Tumors (Tumors of Borderline Malignancy)

  1982cites this paper
• [Ovarian cancer: markers, hormones receptors, immunological status].

  1982cites this paper
• Clinical utility of human chorionic gonadotropin and alpha-subunit measurements.

  1982cites this paper
• Nature of carcinoembryonic antigen purified from malignant ascitic fluid of serous cystadenocarcinoma of the ovary.

  1981cites this paper
• Oncofoetal antigens in cancer of the cervix and ovary.

  1981cites this paper
• A comparison of two radioimmunoassay methods for the detection of carcinoembryonic antigen in patients with ovarian or cervical cancer.

  1981cites this paper
• Plasma carcinoembryonic antigen levels in ovarian cancer patients: a chart review and survey of published data.

  1981cites this paper
• Circulating choriogonadotropin beta subunit in a patient with primary amenorrhea and embryonal ovarian carcinoma.

  1980cites this paper
• Second-Look Laparotomy and Prognosis Related to Extent of Residual Disease

  1980cites this paper
• Immunodetection of Choriogonadotropin-Like Antigen in Bacteria Isolated from Cancer Patients

  1980cites this paper
• Products of gynaecological neoplasms: clinical and pathological applications.

  1980cites this paper
• [Precocious pseudo-puberty due to HCG-secreting androblastoma of the ovary. One case (author's transl)].

  1980cites this paper
• Presence of an hCG-Like Substance in Non-Pregnant Humans

  1980cites this paper
• Indications, advantages, and limits of laparoscopy in ovarian cancer.

  1979cites this paper
• An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.

  1979cites this paper
• The Specific Proteins of the Human Placenta Some New Hypotheses

  1979cites this paper
• Serial determination of marker substances in ovarian cancer.

  1979cites this paper
• Trophoblastic Proteins in Ovarian Carcinoma

  1979cites this paper
• The clinical significance of carcinoembryonic antigen in the plasma and tumors of patients with gynecologic malignancies

  1978cites this paper
• Laparoscopy and peritoneal cytology as markers in the follow-up of ovarian epithelial tumors.

  1978cites this paper
• Kinetics of growth and ectopic production of human chorionic gonadotropin by an ovarian cystadenocarcinoma cell line maintained in vitro.

  1978cites this paper
• Immunohistochemical localization of a choriogonadotropin‐like protein in bacteria isolated from cancer patients

  1978cites this paper
• Influence of chemotherapeutic agents on chorionic gonadotropin-alpha subunit secretion in a human lung cancer cell line (ChaGo): discordance of cytotoxic and secretory effects.

  1978cites this paper
• Combined Batchwise and Continuous Flow Mechanization of Solid-Phase Radioimmunoassays

  1978cites this paper
• Multiple Fetal Antigens in Germ‐cell Tumors

  1978cites this paper
• Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors. Circulating levels and tissue localization

  1978cites this paper
• Clinical relevance of research on the structure of human chorionic gonadotropin.

  1977cites this paper
• Immunologic studies on the cystic effusions of ovarian epithelial neoplasms.

  1977cites this paper
• Maintenance of ectopic chorionic gonadotropin and alpha subunit secretion by a human lung cancer cell line (ChaGo) transplanted into nude mice.

  1977cites this paper
• The use of laparoscopy to determine the results of chemotherapy for ovarian cancer.

  1977cites this paper
• Essai de codification d'une thérapeutique multidisciplinaire des carcinomes du revêtement ovarien

  1977cites this paper